Aurora Sheboygan Prices: Long-Acting Release Injection Octreotide Per Dose is $7,970.00

The long-acting release injection of Octreotide is a specialized medication used to manage symptoms of acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors. Priced at $7,970.00 per dose at Aurora Medical Center Sheboygan County, this fee typically covers the cost of the medication itself and professional administration by healthcare staff. Octreotide’s extended-release formulation allows for monthly dosing, offering sustained symptom control and improved convenience for patients. Given the high cost and complexity of such treatments, patients are advised to request an itemized estimate in advance and verify insurance coverage or financial assistance options.

Cost Breakdown

• Medication cost: $7,970.00 per injection (covers the long-acting Octreotide formulation)
• Administration fee: May be included, but confirm with the provider as some facilities charge separately for professional administration
• Facility charges: Additional fees for clinic use or supplies may apply; always request a full itemized bill

Associated Costs to Consider

• Pre-injection lab tests or imaging
• Follow-up visits to monitor response and side effects
• Potential emergency or urgent care if severe reactions occur
• Other medications for symptom management or side-effect control

Insurance & Payment Advice

• Contact your insurer to confirm if Octreotide injections are covered and what your out-of-pocket costs (copay, coinsurance, deductible) may be
• Ask if pre-authorization is required prior to treatment
• Inquire about manufacturer assistance programs for high-cost medications
• If uninsured or underinsured, ask the hospital’s billing office about financial counseling or payment plans

Side-Effect Considerations & Recovery Tips

• Common side effects include gastrointestinal symptoms, injection site reactions, and gallstones; report persistent or severe symptoms to your provider
• Follow all aftercare instructions post-injection to minimize discomfort
• Maintain regular appointments for monitoring hormone levels and overall health

Frequently Asked Questions

• What is Octreotide used for?
  Octreotide is used to manage symptoms of acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors by inhibiting excess hormone secretion.
• How is the long-acting release injection administered?
  This injection is given intramuscularly by a healthcare professional, typically once every four weeks.
• Why is the cost of Octreotide so high?
  The cost reflects the medication’s specialized formulation, the complexity of manufacture, and its use for rare or serious conditions.
• Does the price include all associated care costs?
  Generally, the listed price covers the medication itself; administration, facility, and follow-up charges may be billed separately.
• Will my insurance cover this injection?
  Coverage varies; contact your insurance provider to confirm benefits, prior authorization requirements, and out-of-pocket costs.
• Are there financial assistance options available?
  Many manufacturers, hospitals, and nonprofits offer assistance programs; ask the billing office or your provider for details.
• What side effects should I watch for after the injection?
  Common side effects include gastrointestinal issues, pain at the injection site, and, rarely, gallstones. Notify your provider if you experience severe or persistent symptoms.
• How often will I need this injection?
  Most patients receive the long-acting release injection every four weeks, but your schedule may vary based on your condition and response to treatment.
• Can I get this medication at a different facility for a lower price?
  Pricing can vary between hospitals and regions; compare costs and ask for itemized estimates from multiple providers if possible.
• What happens if I miss a scheduled injection?
  Contact your healthcare provider as soon as possible to reschedule and discuss any symptoms or concerns.
• Are there alternatives to Octreotide?
  Other medications or formulations may be available depending on your diagnosis; discuss options and costs with your specialist.

Aurora Medical Center Sheboygan County offers a range of medical services, including specialized treatments such as the long-acting release injection of Octreotide. This particular medication is used to manage symptoms associated with certain medical conditions, such as acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors. The cost for each dose of this long-acting release injection is $7,970.00, as per the pricing information provided by Aurora Sheboygan. This pricing reflects the specialized nature of the medication, which is designed to provide extended therapeutic effects, reducing the frequency of administration and potentially improving patient compliance and outcomes.

What is Octreotide and what is it used for? – Octreotide is a medication used to treat symptoms of certain hormonal disorders, such as acromegaly, and to manage symptoms of carcinoid tumors and vasoactive intestinal peptide tumors by mimicking natural somatostatin, inhibiting the release of various hormones and substances.

How is the long-acting release injection of Octreotide administered? – The long-acting release injection of Octreotide is typically administered by a healthcare professional as an intramuscular injection, usually once every four weeks, allowing for sustained release and prolonged therapeutic effects.

Why is the cost of Octreotide so high? – The cost of Octreotide is high due to its complex manufacturing process, the specialized nature of the medication, and its role in treating rare and serious conditions, which often require advanced pharmaceutical technology and research.

Are there any side effects associated with Octreotide? – Yes, common side effects of Octreotide may include gastrointestinal issues such as nausea, diarrhea, and abdominal pain, as well as potential gallbladder problems, changes in blood sugar levels, and injection site reactions.

Is Octreotide covered by insurance? – Coverage for Octreotide can vary depending on the patient’s insurance plan; it’s important for patients to check with their insurance provider to determine the extent of coverage and any out-of-pocket costs.

Can Octreotide be used in pediatric patients? – The use of Octreotide in pediatric patients is generally limited and should be considered on a case-by-case basis, with careful evaluation by a healthcare provider to assess the potential benefits and risks.

What should patients discuss with their doctor before starting Octreotide? – Patients should discuss their full medical history, any current medications, potential allergies, and any existing health conditions with their doctor to ensure Octreotide is a safe and appropriate treatment option for them.